The article contrasts Coca-Cola vs. PepsiCo ahead of 2026, highlighting that rising GLP-1-driven demand is shifting consumers toward lower-calorie beverages and savory snacks. Coca-Cola FY2025 revenue was about $48.1B (+2.6%) with net income of ~$13.1B and FCF ~$5.3B, while PepsiCo FY2025 revenue was about $93.9B (+2.3%) with net income ~$8.2B and FCF ~$7.7B; it also flags regulatory/legal risks (Coke IRS claims near $3.3B, sugar taxes/packaging standards) and customer concentration (Coke’s top bottler ~10% of net operating revenues; Pepsi’s Walmart-related ~14%). Valuation shows Pepsi trading cheaper on P/E (22.6x vs 25.1x) and especially P/S (2.1x vs 7.1x), while dividend yields differ (Pepsi 4.9% vs Coke 2.6%) and the article cites higher expected net income margin for Coke (~29% vs Pepsi ~11.2%). Overall, the piece is balanced with modestly valuation-leaning support for Pepsi but countered by Coke’s margin profile.
This is less a debate about soda and more a debate about who owns the new consumer basket. The market is likely underpricing the fact that GLP-1 adoption and household belt-tightening do not simply destroy demand; they redistribute it toward smaller servings, zero-sugar formats, energy/functional drinks, and salty convenience snacks. That makes the relative winner more about mix management than raw volume growth, and it puts the burden of proof on whichever name cannot protect price-pack architecture.
From a competitive standpoint, the cleaner second-order beneficiaries are energy beverage leaders and private-label snack suppliers, while the clearest losers are undifferentiated sugary beverage SKUs and brands reliant on promo-heavy retail shelves. Pepsi’s snack exposure gives it more optionality if savory outgrows sweet, but it also leaves it more exposed to retailer bargaining power and margin leakage if WMT-style customers push for value packs. Coke’s higher-margin model is sturdier, yet its premium valuation leaves less room for disappointment if global beverage growth stays mid-single-digit and bottler negotiations turn less favorable.
Over the next 1-3 months, the catalyst is not headline sales but commentary on elasticity, mix, and promo intensity; that is where the next estimate revisions will come from. Over 6-18 months, the key question is whether both can re-rate as health-conscious compounders, or whether rising rates and normalized category growth compress the defensive multiple premium. The contrarian take is that the market may be overestimating long-term soda destruction from GLP-1s and underestimating how much margin can be preserved by smaller packs and better-for-you innovation, but PEP still looks cheaper for a reason: execution and leverage matter if consumer demand softens.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment